Drug Insight: rituximab in renal disease and transplantation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Nephrology,General Medicine
Link
http://www.nature.com/articles/ncpneph0133.pdf
Reference62 articles.
1. Anolik JH et al. (2003) The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus. Arthritis Rheum 48: 455–459
2. Teeling JL et al. (2004) Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas. Blood 104: 1793–1800
3. McLaughlin P et al. (1998) Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 16: 2825–2833
4. Mohrbacher A (2005) B cell non-Hodgkin's lymphoma: rituximab safety experience. Arthritis Res Ther 7 (Suppl 3): S19–S25
5. Edwards JC et al. (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350: 2572–2581
Cited by 114 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The podocyte: glomerular sentinel at the crossroads of innate and adaptive immunity;Frontiers in Immunology;2023-07-26
2. Update on the Application of Monoclonal Antibody Therapy in Primary Membranous Nephropathy;Drugs;2023-04
3. Ophiopogonin D attenuates the progression of murine systemic lupus erythematosus by reducing B cell numbers;Journal of Biochemical and Molecular Toxicology;2023-03-31
4. HER-2-targeted boron neutron capture therapy using an antibody-conjugated boron nitride nanotube/β-1,3-glucan complex;Nanoscale Advances;2023
5. New and Old Anti-CD20 Monoclonal Antibodies for Nephrotic Syndrome. Where We Are?;Frontiers in Immunology;2022-02-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3